Suit: Neurontin Marketed Illegally for Bipolar...

Not only does the lawsuit allege that Parke-Davis marketed Neurontin to physicians without FDA approval - but research studies say Neurontin is not effective for bipolar disorder after all.

Source: About.com Bipolar Disorder - June 15, 2013 Category: Psychiatry Authors: bipolar.guide at about.com Tags: health Source Type: news